Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
3
×
glaxosmithkline
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
alzheimer's disease
biogen
bristol-myers squibb
cancer
crispr
fda
gene therapy
ipo
What
bio
roundup
companies
news
approval
august
biogen’s
biopharmaceutical
biotech
black
busy
continue
convo
days
debut
decisions
devices
diamond
diamond’s
drug
drugs
earlier
failures
fda
indication
leading
legacy
life
littered
mammoth
march
moves
nash
new
nods
ohana’s
opioid
past
pop
price
Language
unset
Current search:
glaxosmithkline
×
abbvie
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More